523 F.Supp.3d 523
S.D.N.Y.2021Background
- Hello Products sells activated-charcoal toothpastes marketed as "epic whitening," "whitens naturally," "detoxifier," and "safe/gentle for daily use." Plaintiffs bought Hello charcoal toothpastes after seeing packaging and online ads.
- Plaintiffs (Patellos and Fishon) allege the products failed to whiten, are abrasive to enamel, and can cause long-term dental harm; they also allege they paid a premium for purported charcoal benefits.
- SAC asserts seven claims: breach of express warranty (UCC §2-313); breach of implied warranty (UCC §2-314); deceptive practices (GBL §349); false advertising (GBL §350); negligent misrepresentation; intentional misrepresentation/fraud; unjust enrichment.
- Hello moved to dismiss, arguing preemption of fluoride-related claims, failure to plead fraud with particularity (Rule 9(b)), lack of UCC notice, no privity for implied-warranty and negligent-misrepresentation claims, and that unjust enrichment duplicates other claims.
- Court dismissed any claims challenging fluoride (plaintiffs abandoned them), found fraud-based and GBL claims adequately pleaded, denied dismissal of express warranty, fraud, and GBL claims, and granted dismissal of implied warranty, negligent misrepresentation, and unjust enrichment; injunctive relief was denied for lack of standing.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Federal preemption of fluoride-related claims | Plaintiffs do not challenge fluoride safety/efficacy; only assert charcoal effects | Hello: FDA monograph preempts state-law challenges to fluoride representations | Court: Plaintiffs abandoned fluoride claims; any such claims dismissed as preempted/abandoned |
| Particularity under Rule 9(b) for fraud-based claims | Alleged detailed statements, sources, and plaintiffs’ experiences showing falsity | Hello: Allegations are conclusory and lack the "how" of fraud (e.g., how enamel abrasion was determined) | Court: SAC meets Rule 9(b) — detailed statements, speakers, timing, and why false; fraud-based claims survive |
| UCC §2-607(3) notice for express warranty | Plaintiffs: timely notice via filing and service of original complaint within months of discovery | Hello: Complaint is not proper or timely notice | Court: Timing is fact question; complaint may suffice as notice here — express warranty claim survives |
| Implied warranty (privity) | Plaintiffs allege privity or third-party beneficiary status | Hello: Purchases occurred via Amazon/Target; no privity with Hello; bare assertions insufficient | Court: Dismissed implied warranty claim for failure to plead facts showing privity or intended third-party beneficiary status |
| Negligent misrepresentation (special relationship/privity-like duty) | Plaintiffs point to Hello’s R&D scientist and website content to show reliance and special relationship | Hello: Website marketing and ads do not create a special, privity-like relationship | Court: Dismissed negligent misrepresentation for failure to plead the required special relationship |
| Unjust enrichment duplicative of other claims | Plaintiffs: unjust enrichment may seek disgorgement and alternative theories | Hello: It duplicates contract/tort claims | Court: Dismissed unjust enrichment as duplicative of other viable claims |
| Injunctive relief (standing) | Plaintiffs: continued inability to rely on labels; may repurchase if truthful labeling ensured | Hello: Plaintiffs lack imminent, concrete injury for prospective relief | Court: Denied injunctive relief for lack of actual and imminent future harm |
Key Cases Cited
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility pleading standard)
- Ashcroft v. Iqbal, 556 U.S. 662 (labels-and-conclusions insufficient)
- Eternity Global Master Fund Ltd. v. Morgan Guar. Tr. Co. of N.Y., 375 F.3d 168 (Rule 9(b) specificity requirements)
- Aetna Cas. & Sur. Co. v. Aniero Concrete Co., 404 F.3d 566 (privity-like "special relationship" standard for negligent misrepresentation)
- Corsello v. Verizon N.Y., Inc., 18 N.Y.3d 777 (unjust enrichment is not available where duplicative of tort or contract claims)
- Berni v. Barilla S.p.A., 964 F.3d 141 (standing/injunctive-relief requirement of imminent future harm)
- Canale v. Colgate-Palmolive Co., 258 F. Supp. 3d 312 (FDA monograph limits state-law challenges to monograph-covered drug claims)